project id: TCGA-KIRP; case submitter id: TCGA-2K-A9WE; analyte type: DNA; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.73; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.55; rna integrity number: 7.8; age at index: 53; days to birth: -19603; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1960; age at diagnosis: 19603; ajcc clinical m: M0; ajcc clinical n: NX; ajcc clinical t: T2b; ajcc pathologic m: M0; ajcc pathologic n: NX; ajcc pathologic stage: Stage II; ajcc pathologic t: T2b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 214.0; icd 10 code: C64.1; last known disease status: not reported; morphology: 8260/3; primary diagnosis: Papillary adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Kidney, NOS; synchronous malignancy: No; tissue or organ of origin: Kidney, NOS; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 105; days to sample procurement: 0; initial weight: 370.0; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 15.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 60.0;